What is Hemodialysis & Peritoneal Dialysis Market Scope?
Dialysis is a technique for removing waste products such as urea and creatinine from the blood, caused by inadequate kidney function and usually required in people with chronic kidney failure. This procedure is used to treat kidney disease and is divided into two types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped from blood vessels and cleaned with the aid of a dialyzer, and then returned to the body via vascular access. In peritoneal dialysis, the principle of the procedure remains the same, but the inner stomach lining known as the peritoneum is used as a filter to cleanse the blood. Market growth is mainly driven by factors such as the increasing number of ESRD patients, the increasing prevalence of diabetes and high blood pressure (major causes of kidney failure), and the preference for dialysis treatments over kidney transplants due to a lack of donors. In addition, the increase in the number of dialysis centers around the world, organ donor shortages and transplant risks, technological advances, and initiatives by leading players to introduce advanced products and services provide growth opportunities for the Hemodialysis and Peritoneal Dialysis market. The other factors that contribute to the decreased preference for kidney transplants are a patient aversion to organ donation, financial constraints, lack of adequate surgical facilities, risks of surgery such as organ rejection, and complications from side effects of immunosuppressive drugs. These challenges associated with kidney transplants have resulted in a low preference for these procedures, which in turn has led to an increase in the number of patients who have opted for dialysis.
The Hemodialysis & Peritoneal Dialysis market study is being classified by Type (Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] and Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from European will contribute to the maximum growth of Global Hemodialysis & Peritoneal Dialysis market throughout the predicted period.
Fresenius Medical Care AG & Co. KGAA (Germany), DaVita Healthcare Partners Inc. (United States), Becton, Dickinson, and Company (United States), Medtronic plc (Ireland), Baxter International Inc. (United States), B. Braun Melsungen AG (Germany), Diaverum Deutschland Gmbh (Germany), Nipro Corporation (Japan), Asahi Kasei Medical Co., Ltd. (Japan), Nikkiso Co., Ltd. (Japan), 3M (United States), Toray Industries, Inc. (Japan), Davita Healthcare Partners Inc. (United States), Isopure Corp. (United States) and Mar Cor (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Atlantic Biomedical (India), Dialife SA (Switzerland), Allmed Medical Care Holdings Limited (United Kingdom), Rockwell Medical Inc. (United States) and JMS Co. Ltd. (Japan).
Analyst at AMA have segmented the market study of Global Hemodialysis & Peritoneal Dialysis market by Type, Application and Region.
On the basis of geography, the market of Hemodialysis & Peritoneal Dialysis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In 2019, Fresenius Medical Care had acquired NxStage Medical, Inc., which is a US-based home dialysis leader. With this acquisition, the company had aimed to expand its presence in the dialysis market
In 2018, B. Braun Melsungen AG had opened a production site for dialyzers in Saxony (Germany) that was thereby aimed at increasing access to an advanced dialysis product in the country
Influencing Market Trend
- Growing Prevalence of Diabetes & Hypertension Which Is a Major Causes of Kidney Failure
- The Growing Incidence of ESRD
- The Rising Acceptance of Home Hemodialysis and Peritoneal Dialysis
- The Increasing Number of Dialysis Centers across the Globe
- A Rise in New Product Launches
- The Availability of Healthcare Professionals in Dialysis Centers
- Increasing Per Capita Income
- The Increasing Geriatric Population
- Improving Healthcare Infrastructure
- Supportive Government Activities in the Emerging Countries
- Reimbursement Concerns in Emerging Market
- Rise in Complications Related To Dialysis Treatment
- Lack of Sufficient Surgical Facilities
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Providers of Hemodialysis & Peritoneal Dialysis, Venture Capitalists and Private Equity Firms and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.